StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech cash

Cash and short-term investments held at the end of each period.

Goldenwell Biotech's cash was $11.14K at Jun 30, 2026. For fiscal 2025 it was $26.78K, down 45.8% from the year before. The highest annual figure on record is $248.57K in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$26.78K-45.8%
FY2024Dec 31, 2024$49.40K-7.2%
FY2023Dec 31, 2023$53.23K+15.7%
FY2022Dec 31, 2022$46.00K-78.5%
FY2021Dec 31, 2021$213.56K-14.1%
FY2020Dec 31, 2020$248.57K+0.8%
FY2019Dec 31, 2019$246.59K–
FY2018Dec 31, 2018$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.14K-85.4%
Q1 FY2026Mar 31, 2026$13.41K-21.7%
Q4 FY2025Dec 31, 2025$26.78K-45.8%
Q3 FY2025Sep 30, 2025$45.62K+859.5%
Q2 FY2025Jun 30, 2025$76.51K+197.5%
Q1 FY2025Mar 31, 2025$17.13K-29.3%
Q4 FY2024Dec 31, 2024$49.40K-7.2%
Q3 FY2024Sep 30, 2024$4.76K-60.1%
Q2 FY2024Jun 30, 2024$25.72K+50.1%
Q1 FY2024Mar 31, 2024$24.22K-45.0%
Q4 FY2023Dec 31, 2023$53.23K+15.7%
Q3 FY2023Sep 30, 2023$11.92K-79.5%
Q2 FY2023Jun 30, 2023$17.13K-60.0%
Q1 FY2023Mar 31, 2023$44.08K-79.4%
Q4 FY2022Dec 31, 2022$46.00K-78.5%
Q3 FY2022Sep 30, 2022$58.09K-75.1%
Q2 FY2022Jun 30, 2022$42.86K-82.5%
Q1 FY2022Mar 31, 2022$213.56K-14.1%
Q4 FY2021Dec 31, 2021$213.56K-14.1%
Q3 FY2021Sep 30, 2021$232.93K-7.0%
Q2 FY2021Jun 30, 2021$245.44K-2.4%
Q1 FY2021Mar 31, 2021$248.57K-1.2%
Q4 FY2020Dec 31, 2020$248.57K+0.8%
Q3 FY2020Sep 30, 2020$250.54K–
Q2 FY2020Jun 30, 2020$251.42K–
Q1 FY2020Mar 31, 2020$251.56K–
Q4 FY2019Dec 31, 2019$246.59K–
Q3 FY2019Sep 30, 2019$0–
Q4 FY2018Dec 31, 2018$0–

More Goldenwell Biotech figures

See a number that looks wrong?